Masanao Shinohara
Papers
1
Total Citations
5
H-Index
1
About
Masanao Shinohara is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for muscle-invasive bladder cancer (MIBC), with a particular emphasis on comparing robotic and open surgical approaches. His major contributions center on evaluating the oncologic safety and prognostic implications of robot-assisted radical cystectomy (RARC) versus open radical cystectomy (ORC). In his most cited multicenter retrospective study (2025, 5 citations), Shinohara and colleagues investigated the incidence of peritoneal carcinomatosis and long-term prognosis in 429 MIBC patients, providing critical real-world evidence that helps surgeons weigh the benefits of minimally invasive techniques against potential oncologic risks. This work addresses a key clinical debate in urologic oncology, offering data-driven guidance for treatment decision-making. Shinohara’s research is instrumental in advancing surgical precision and patient outcomes, and his findings are widely referenced by clinicians and researchers seeking to refine bladder cancer management strategies. His dedication to evidence-based practice and collaborative multicenter research underscores his impact on the field.
Research Focus
Key Achievements
Top Papers
- 1